Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets

Area of Science:

• Oncology
• Genomics
• Cancer Biology

Background:

• Intimal sarcomas are rare, heterogeneous tumors originating from pulmonary arteries, posing significant treatment challenges.
• Limited genomic studies exist for intimal sarcomas, hindering the identification of targetable alterations.
• Understanding the genetic landscape is crucial for advancing treatment strategies.

Purpose of the Study:

• To catalog genetic alterations in intimal sarcoma using a large patient database.
• To assess the clinical utility of identified genomic alterations.
• To identify potential therapeutic targets for intimal sarcoma.

Main Methods:

• Utilized data from the American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange (AACR GENIE) database.
• Cataloged genetic alterations including copy number variations, mutations, and genomic rearrangements in 13 intimal sarcoma patients.
• Assessed the clinical utility and co-occurrence of identified alterations.

Main Results:

• Identified copy number amplifications in MDM2, CDK4, PDGFRA, and NOTCH2, and losses in CDKN2A and CDKN2B.
• Detected actionable mutations in ATM/ATR, PTCH1, and PDGFRB.
• Discovered genomic rearrangements, specifically PDE4DIP-NOTCH2 and MRPS30-ARID2 fusions, with co-occurring NOTCH2 gain and PDGFRB mutations.

Conclusions:

• The study identified significant genetic alterations in intimal sarcoma, including potential drivers like PDGFRB.
• Genomic profiling is warranted for intimal sarcoma management.
• Findings support considering patients for targeted therapy clinical trials.